PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics

Ovarian cancer is the most lethal gynecologic malignancy in the United States, with an estimated 22,530 new cases and 13,980 deaths in 2019. Recent studies have indicated that the phosphoinositol 3 kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR), as well as the nuclear fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghoneum, Alia, Said, Neveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679095/
https://www.ncbi.nlm.nih.gov/pubmed/31284467
http://dx.doi.org/10.3390/cancers11070949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679095/
https://www.ncbi.nlm.nih.gov/pubmed/31284467
http://dx.doi.org/10.3390/cancers11070949

Ejemplares similares